The first case of breast cancer in thalassemic patient: case report and review of literature

References

• Moschovi M, Psychou F, Menegas D, et al. Hodgkin’s disease in a child with sickle cell disease treated with hydroxyurea. Pediatr Hematol Oncol 2001;18:371–6
   PubMed Web of Science ®Google Scholar
• Kaloterakis A, Filiotou A, Konstantopoulos K, et al. Multiple myeloma in sickle cell syndromes. Haematologia 2001;31:153–9
   PubMedGoogle Scholar
• Chehal A, Loutfi R, Taher A. Beta-thalassemia intermedia and non-Hodgkin’s lymphoma. Hemoglobin 2002;26:219–25
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Terpos E, Komninaka V, et al. Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassemia major: complete haematological remission under the combination of hydroxyurea and anagrelide. Br J Haematol 2002;116:155–7
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassemia syndromes. Br J Haematol 2004;1241:114–17
   Web of Science ®Google Scholar
• Ricchi A, Carta A, Pinna GM, et al. Asymptomatic cardiac lymphoma in a hepatitis C virus-positive thalassemic patient. Ital Heart J 2004;5:302–4
   PubMedGoogle Scholar
• Mancuso A, Rigano P, Renda D, et al. Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infercted thalassemic. Am J Hematol 2005;78:158–9
   PubMed Web of Science ®Google Scholar
• Jabr FI, Aoun E, Yassine H, et al. Beta-thalassemia intermedia and Hodgkin lymphoma. Am J Hematol 2006;81:151
   PubMed Web of Science ®Google Scholar
• Otrock ZK, Shamseddine AI, Taher AT. Non-Hodgkin disease in β-thalassemiamajor. AmJ Hematol 2006;81:62–4
   PubMed Web of Science ®Google Scholar
• Benetatos L, Alymara V, Vassou A, Bourantas KL. Malignancies in β-thalassemia patients: a single center experience and a concise review of the literature. Int J Lab Hematol 2008;30:167–72
   PubMed Web of Science ®Google Scholar
• Karimi M, Giti R, Haghpanah S, et al. Malignancies in patients with β-thalassemia major and β-thalassemia intermedia: a multicenter study in Iran. Pediatr Blood Cancer 2009;53:1064–7
   PubMed Web of Science ®Google Scholar
• Restivo Pantalone G, Renda D, Valenza F, et al. Hepatocellular carcinoma in patients with thalassemia syndromes: clinical characteristics and outcome in a long term single centre experience. Br J Haematol 2010;150:245–7
   PubMed Web of Science ®Google Scholar
• Ansari S, Azarkivan A, Halagi F. Incidence of hepatocellular carcinoma in patients with thalassemia who had hepatitis C. Acta Medica Iranica 2013;51:404–7
   PubMedGoogle Scholar
• Poggi M, Sorrentino F, Pascucci C, et al. Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature. Hemoglobin 2011;35:439–46
   PubMed Web of Science ®Google Scholar
• Russo A, Schiliro G. Thalassemia major and malignancies. Am J Hematol 1987;24:111–112. (b) Miniero R, Saracco P. Cancer in thalassemia and other hemoglobinopathies. Am J Hematol 1988;27:74
   PubMed Web of Science ®Google Scholar
• Gnant M, Harbeck N, Thomssen C. St. Gallen 2011: summary of the consensus discussion. Breast Care 2011;6:136–41
   PubMed Web of Science ®Google Scholar
• Bletsa G, Zagouri F, Gounaris A, et al. Beta-thalassemia major: does it confer particularities to the breast? Breast J 2013;19:124–5
   PubMed Web of Science ®Google Scholar
• Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med 2005;353:1135–46
   PubMed Web of Science ®Google Scholar
• Angelucci E, Barosi G, Camaschella C, et al. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica 2008;93:741–52
   PubMed Web of Science ®Google Scholar
• Joosten E, Meeuwissen J, Vandewinckele H, Hiele M. Iron status and colorectal cancer in symptomatic elderly patients. Am J Med 2008;121:1072–7
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 2004;1241:114–17
   Web of Science ®Google Scholar
• Chen J, Geissler C, Parpia B, et al. Antioxidant status and cancer mortality in China. Int J Epidemiol 1992;21:625–35
   PubMed Web of Science ®Google Scholar
• Huang Y-L, Sheu J-Y, Lin T-H. Association between oxidative stress and changes in trace elements in patients with breast cancer. Clin Biochem 1999;32:131–6
   PubMed Web of Science ®Google Scholar
• Zacharski L, Chow B, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008;100:996–1002
   PubMed Web of Science ®Google Scholar
• Bletsa G, Zagouri F, Gounaris A, et al. Beta-thalassemia major: does it confer particularities to the breast? Breast J 2013;19:124–5
   PubMed Web of Science ®Google Scholar
• De Bruijn KM, Arends LR, Hansen BE, et al. Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer. Br J Surg 2013;100:1421–9
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Pasanisi P, Abbà C, et al. Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study. Clin Breast Cancer 2012;12:175–82
   PubMed Web of Science ®Google Scholar
• Greif JM. Mammographic screening for breast cancer: an invited review of the benefits and costs. Breast 2010;19:268–72
   PubMed Web of Science ®Google Scholar
• Tripatara A, Jetsrisuparb A, Teeratakulpisarn J, Kuaha K. Hemostatic alterations in splenectomized and non-splenectomized patients with beta–thalassemia/hemoglobin E disease. Thromb Res 2007;120:805–10
   PubMed Web of Science ®Google Scholar
• Borgna Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99:76–9
   PubMed Web of Science ®Google Scholar
• Valenti L, Pulixi EA, Arosio P, et al. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 2007;92:1037–42
   PubMed Web of Science ®Google Scholar